Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease

Part of paid clinical trials in Palo Alto, California.

Sponsor
MMI (Medical Microinstruments, Inc.)
Study ID
NCT07178210
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Symani Surgical System — DEVICE
    Use of Symani Surgical System for performing microsurgical techniques in the deep cervical lymph nodes.

Study Details

The objective of this investigational device exemption (IDE) study is to evaluate the safety and feasibility of using the Symani System and microsurgical techniques in the deep cervical lymph node (dCLN) region in the setting of mild to moderate Alzheimer's disease and lymphatic abnormalities.

Key Dates

Start date
Apr 30, 2026
Status verified
Jun 2026
Primary completion
Oct 30, 2026
Completion
Oct 30, 2027

Study Design

Enrollment
15 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Alzheimer's Disease
    Patient with confirmed mild to moderate Alzheimer's Disease according to the National Institute of Aging-Alzheimer's Association (NIA-AA) criteria

Primary Outcome Measure

Device-related serious adverse events at 30-days [ Time Frame: The duration of the participants' index procedure through 30-days post index procedure. ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Stanford Medical CenterPalo AltoCalifornia94305
Elizabeth Tadevosyan
[email protected]
Dung Nguyen, MD (PRINCIPAL_INVESTIGATOR)
Baptist Health Research InstituteJacksonvilleFlorida32207
Karen Yesensky
[email protected]
904-202-7091
Ricardo Hanel, MD, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Palo Alto, CA

By condition
Alzheimer's disease
By specialty
NeurologyDementia careBrain disordersGeriatrics
By research site
Stanford Medical Center· Palo Alto, CABaptist Health Research Institute· Jacksonville, FL

Related Studies